Table 4 Correlations of CD3/CD4/CD8/CD66b density with clinicopathological characteristics

Age

0.218

0.786

0.917

0.540

 < 60 yrs

29(50.0%)

35(61.4%)

31(54.4%)

33(56.9%)

32(56.1%)

32(55.2%)

24(52.2%)

40(58.0%)

 ≥ 60 yrs

29(50.0%)

22(38.6%)

26(45.6%)

25(43.1%)

25(43.9%)

26(44.8%)

22(47.8%)

29(42.0%)

Gender

0.225

0.263

0.113

0.046

 Male

49(84.5%)

43(75.4%)

48(84.2%)

44(75.9%)

49(86.0%)

43(74.1%)

41(89.1%)

51(73.9%)

 Female

9(15.5%)

14(24.6%)

9(15.8%)

14(24.1%)

8(14.0%)

15(25.9%)

5(10.9%)

18(26.1%)

Etiology

0.225

0.225

0.834

0.081

 HBV

46(79.3%)

50(87.7%)

50(87.7%)

46(79.3%)

48(84.2%)

48(82.8%)

35(76.1%)

61(88.4%)

 Others

12(20.7%)

7(12.3%)

7(12.3%)

12(20.7%)

9(15.8%)

10(17.2%)

11(23.9%)

8(11.6%)

AFP

0.162

0.108

0.392

0.358

 < 100 ng/mL

36(62.1%)

28(49.1%)

36(63.2%)

28(48.3%)

34(59.6%)

30(51.7%)

28(60.9%)

36(52.2%)

 ≥ 100 ng/mL

22(25.7%)

29(50.9%)

21(36.8%)

30(51.7%)

23(25.3%)

28(48.3%)

18(39.1%)

33(47.8%)

Tumor size

0.115

0.639

0.198

0.505

 ≤ 5 cm

37(40.9%)

44(40.1%)

39(68.4%)

42(72.4%)

37(64.9%)

44(75.9%)

34(73.9%)

47(68.1%)

 > 5 cm

21(36.2%)

13(22.8%)

18(31.6%)

16(27.6%)

20(35.1%)

14(24.1%)

12(26.1%)

22(31.9%)

Tumor number

0.749

0.749

0.708

0.777

 Single

53(91.4%)

53(93.0%)

53(93.0%)

53(91.4%)

52(91.2%)

54(93.1%)

42(91.3%)

64(92.8%)

 Multiple

5(8.6%)

4(7.0%)

4(7.0%)

5(8.6%)

5(8.8%)

4(6.9%)

4(8.7%)

5(7.2%)

ES grade

0.518

0.306

0.914

0.817

 Well/Moderate

23(39.7%)

26(45.6%)

27(47.4%)

22(37.9%)

24(42.1%)

25(43.1%)

19(41.3%)

30(43.5%)

 Poor

35(60.3%)

31(54.4%)

30(52.6%)

36(62.1%)

33(57.9%)

33(56.9%)

27(58.7%)

39(56.5%)

Vascular invasion

0.954

0.635

0.191

0.445

 Absent

42(72.4%)

41(71.9%)

40(70.2%)

43(74.1%)

38(66.7%)

45(77.6%)

35(76.1%)

48(69.6%)

 Present

16(27.6%)

16(28.1%)

17(29.8%)

15(25.9%)

19(33.3%)

13(22.4%)

11(23.9%)

21(30.4%)